Skip to content
Operation Infinite Justice – Lifestyle
Author:
Femasys Inc.
Femasys Strengthens and Extends Global Patent Protection for FemBloc® with First Issued Blended Polymer Patents
August 12, 2026
Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million
August 7, 2026
Femasys Regains Compliance with Nasdaq Listing Requirements
June 24, 2026
Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter
May 13, 2026
Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update
May 11, 2026
Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed® Complete
May 7, 2026
Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed® Complete
May 7, 2026
Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026
April 24, 2026
Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026
April 24, 2026
Femasys Drives International Growth with Israeli Market Entry for Fertility Portfolio
April 16, 2026
1
2
Next Page
→